TWEIX | VIVAX | TWEIX / VIVAX | |
Total Expense Ratio | 0.93 | 0.17 | 547% |
Annual Report Gross Expense Ratio | 0.93 | 0.17 | 547% |
Fund Existence | 31 years | 32 years | - |
Gain YTD | -0.851 | -4.410 | 19% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.6B | 191B | 3% |
Annual Yield % from dividends | 2.32 | 2.14 | 109% |
Returns for 1 year | -0.07 | 4.75 | -2% |
Returns for 3 years | -9.89 | 9.56 | -103% |
Returns for 5 years | 18.60 | 64.96 | 29% |
Returns for 10 years | 14.28 | 90.77 | 16% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NSMAX | 28.11 | 0.25 | +0.90% |
Nuveen Small/Mid-Cap Value A | |||
PSVKX | 14.30 | 0.11 | +0.78% |
PGIM Quant Solutions Small-Cap Val R4 | |||
FKALX | 41.73 | 0.32 | +0.77% |
Federated Hermes Kaufmann Small Cap R6 | |||
GVEZX | 17.55 | 0.07 | +0.40% |
GuideStone Funds Value Equity Investor | |||
OIEPX | 22.35 | 0.03 | +0.13% |
JPMorgan Equity Income R3 |